Company snapshot
Market Cap
$33B
Large-cap2016 — today
10-Year Price
+45%
2016 — today
52-Week Range
$69.10$144.35
Current $78.80· 13%
Featured in rankings
S&P500Most Undervalued Healthcare StocksBest Healthcare Dividend StocksMost Undervalued Value StocksMost Undervalued Dividend StocksMost Undervalued Growth StocksCheapest Large-Cap Stocks
Rankings recomputed after each US market close — see where ZTS stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| CNCCentene Corporation | 23.5 | — |
| ALCAlcon Inc. | 54.7 | 0.5% |
| RVMDRevolution Medicines, Inc. | -21.5 | — |
| ONCBeOne Medicines Ltd. | 5.1 | — |
| ALNYAlnylam Pharmaceuticals, Inc. | 8.8 | — |
| IDXXIDEXX Laboratories, Inc. | 40.8 | — |
| TEVATeva Pharmaceutical Industries Limited | 69.1 | — |
| HUMHumana Inc. | 39.5 | 0.6% |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
13.0
Near historic low
Near historic low — last 10 years
Sector median 25.4below sector
P/B ratio
10.5
Near historic low
Near historic low — last 10 years
Sector median 2.2above sector
EV / EBITDA
10.2
Near historic low
Near historic low — last 10 years
Sector median 15.7below sector
Dividend Yield
2.7%
Near historic high
Near historic highs — last 10 years
Sector median 1.8%above sector
PEG ratio
1.6
Below average
Below the 10-year average
Sector median 1.8in line with sector
FCF Yield
7.2%
Near historic high
Near historic highs — last 10 years
Sector median -12.6%above sector